| No. | Drug Name | Active Ingredient | Date | What It’s Used For |
| 23. | Orbactiv | oritavancin | 8/6/2014 | To treat adults with skin infections0 _# r3 E- u' M8 M7 L
Press Release |
| 22. | | empagliflozin | 8/1/2104 | To improve gylcemic control in adults with type 2 diabetes& H3 M3 _; ]" m
Press Release |
| 21. | | olodaterol | 7/31/2014 | To treat chronic obstructive pulmonary disease) I9 \4 M! H! C" m9 E
Press Release |
| 20.
! k5 D) N! C/ T, K. E
5 b: T" \4 P7 `* j4 i | | idelalisib | 7/23/2014 | To treat patients with trhee types of blood cancers4 L) G0 W) i! r+ B9 f8 s9 K; y' w! `
Press Release |
| 19. | Kerydin
8 u8 m6 l8 ^" d% m' C& E8 I ! t3 \! p' j* e6 C
| tavaborole | 7/7/2014 | For the topical treatment of onychomycosis of the toenails
! o; T8 k+ x% l- Q4 c, ]7 o; @ (No Press Release) |
| 18. | | belinostat | 7/3/2014 | To treat patients with peripheral T-cell lymphoma (PTCL) 2 q5 b2 a P: d' d- F
Press Release |
| 17. | | tedizolid phosphate | 6/20/2014 | To treat adults with skin infections
' O% V2 a2 ^4 J4 N: i& f: w& A2 Y G Press Release |
| 16. | Jublia! C+ k* X { s6 Z
$ a, l5 Q; f5 c) r, e1 z! E$ \
| efinaconazole | 6/6/2014 | Treat mild to moderate onychomycosis (fungal infection), |8 h, I3 \' @: x
No Press Release |
| 15. | Dalvance
, ~5 F* j; Z% t4 O
4 h: R5 R2 @3 Q5 |% M | dalbavancin | 5/23/2014 | To treat adults with skin infections
1 P9 W( R- O6 q3 M7 j- i2 F4 l; V Press Release |
| 14. | Entyvio; w# L+ F: I$ x$ p
& T* u1 G2 W1 x$ z4 S | vedolizumab | 5/20/2014 | To treat adult patients with moderate to severe ulcerative colitis and adult patients with moderate to severe Crohn‘s disease
n# k2 m. a# j* e, L% B* J# n Press Release |
| 13. | Zontivity
6 S: O) Z' |# I* o0 C: M : _& X* e1 S, u% f
| vorapaxar | 5/8/2014 | To reduce the risk of heart attacks and stroke in high-risk patients$ t- k% b/ }2 t# m \7 L* X% b
Press Release |
| 12. | | ceritinib | 4/29/2014 | To treat patients with a certain type of late-stage (metastatic) non-small cell lung cancer (NSCLC)$ K+ R4 s5 t" M0 g
Press Release |
| 11. | | siltuximab | 4/23/2014 | To treat patients with multicentric Castleman’s disease (MCD), a rare disorder similar to lymphoma (cancer of the lymph nodes), `% }, v% t6 U* y" ^- @4 O) L
Press Release |
| 10. | | ramucirumab | 4/21/2014 | To treat patients with advanced stomach cancer or gastroesophageal junction adenocarcinoma6 P# B u- r' O' a" ?
Press Release |
| 9. | | albiglutide | 4/15/2014 | To improve glycemic control, along with diet and exercise, in adults with type 2 diabetes* C3 d8 {/ T1 ^1 ^/ T! }
Press Release |
| 8. | | apremilast | 3/21/2014 | To treat adults with active psoriatic arthritis (PsA)$ m- C1 O! E: u& t5 _2 J
Press Release |
| 7. | | miltefosine | 3/19/2014 | To treat a tropical disease called leishmaniasis0 n, g1 q: K/ R4 i6 X5 ?" m' b
Press Release |
| 6. | | florbetaben F 18 injection | 3/19/2014 | For Positron EmissionTomography (PET) imaging of the brain |
| 5. | | metreleptin for injection | 2/24/2014 | To treat the complications of leptin deficiency& Z6 J3 S8 o# ]' {& j9 @/ F- _
Press Release |
| 4. | | droxidopa | 2/18/2014 | To treat neurogenic orthostatic hypotension (NOH)
5 Y. k V: }( i' a7 ? Press Release |
| 3. | | elosulfase alfa | 2/14/2014 | Treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome)' R& J3 j$ {3 S$ h+ X3 I3 S2 z1 Z+ ?( q
Press Release |
| 2. | | tasimelteon | 1/31/2014 | To treat non-24- hour sleep-wake disorder (“non-24”) in totally blind individuals. Non-24 is a chronic circadian rhythm (body clock) disorder in the blind that causes problems with the timing of sleep.Press Release |
| 1. | | dapaglifozin | 1/8/2014 | To improve glycemic control, along with diet and exercise, in adults with type 2 diabetes
; X d% U" j- F# { Press Release |
|手机版|药群论坛
( 蜀ICP备15007902号 )
收藏
支持
反对